Aflibercept 40 mg/ml
Original notice title
Czechia – Ophthalmologicals – Aflibercept (40 mg/ml)
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
25 / 100
Risk factors
Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.
Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
- Country
- Czech Republic
- CPV
- 33662100 - Ophthalmologicals
- Deadline
- Sep 15, 2026
- Estimated value
- CZK 50.1M (approx. EUR 2.1M)
Overview
Moderate opportunityKey Facts
- CZK 50.1M estimated value
- Supplies contract
- 1 lot
- Duration 48 MONTH
- Continuous supplies of Aflibercept (40 mg/ml) for 48 months.
- Delivery to Central Military Hospital – Military University Hospital Prague.
Show full summary
Open tender by Ústřední vojenská nemocnice – Vojenská fakultní nemocnice Praha for continuous supplies of the medicinal product with active substance Aflibercept (40 mg/ml) for a period of 48 months. The estimated value is 50,148,102.56 CZK. Award based on lowest price. No selection criteria or procurement documents provided in the analysis.
Risks
Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.
Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Pharmaceutical product with active substance Aflibercept at concentration 40 mg/ml.
- Contract duration 48 months.
- EU-funded project (conflicting: XML notice states no EU funds).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Praha, CZE
Website
Buyer profile
Identifier
61383082
Activity
Health
Lots (1)
LOT-0001
Aflibercept (40 mg/ml)
Continuous supplies of Aflibercept (40 mg/ml) for the Central Military Hospital – Military University Hospital Prague.
EUR 2.1M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Nejnižší nabídková cena
Value note
Show original TED data
Original TED description
Předmětem této veřejné zakázky jsou průběžné dodávky léčivého přípravku s léčivou látkou AFLIBERCEPT pro potřeby Ústřední vojenské nemocnice – Vojenské fakultní nemocnice Praha v souladu se zadávacími podmínkami
Procurement Details
- Publication date
- 09 Jul 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 477378-2026
Documents (1)
Similar tenders
Romania – Analgesics – Furnizare medicamente si materiale sanitare
Romania – Medical consumables – Acord- cadru de furnizare materiale sanitare
Poland – Eye care products and corrective lenses – Dostawa soczewek wewnątrzgałkowych oraz zestawów niezbędnych do przeprowadzenia operacji zaćmy oraz sprzętu medycznego jednorazowego i wielorazowego użytku.
North Macedonia – Pharmaceutical articles – Medicinal Products for the Treatment of Rare Diseases in the Republic of North Macedonia for the Period May 2026 – December 2028
Poland – Various medicinal products – Dostawa produktów leczniczych
Poland – Pharmaceutical products – produkty lecznicze w 309 pakietach dla potrzeb Apteki Szpitalnej Wojewódzkiego Szpitala Zespolonego w Elblągu
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
25 / 100
Risk factors
Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.
Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications